References
- Bellver J, Rodriguez-Tabernero L, Robles A, et al. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet 2018;35(1):25–39.
- McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med 2016;375:54–64.
- Rasquin Leon LI, Mayrin JV. Polycystic ovarian disease (Stein-Leventhal syndrome). Treasure Island (FL): StatPearls; 2017.
- Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
- Glueck CJ, Wang P, Fontaine RN, et al. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabol: Clin Exp 1999;48:1589–95.
- Glueck CJ, Phillips H, Cameron D, et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001;75:46–52.
- Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 2003;80:255–8.
- Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007;282:28175–88.
- Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687–94.
- Garces MF, Sanchez E, Ruiz-Parra AI, et al. Serum chemerin levels during normal human pregnancy. Peptides 2013;42:138–43.
- Garces MF, Sanchez E, Acosta BJ, et al. Expression and regulation of chemerin during rat pregnancy. Placenta 2012;33:373–8.
- Carlino C, Trotta E, Stabile H, et al. Chemerin regulates NK cell accumulation and endothelial cell morphogenesis in the decidua during early pregnancy. J Clin Endocrinol Metabol 2012;97:3603–12.
- Duan DM, Niu JM, Lei Q, et al. Serum levels of the adipokine chemerin in preeclampsia. J Perinat Med 2011;40:121–7.
- Bozaoglu K, Segal D, Shields KA, et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metabol 2009;94:3085–8.
- Ernst MC, Issa M, Goralski KB, et al. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010;151:1998–2007.
- Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009;58:2731–40.
- Tan BK, Chen J, Farhatullah S, et al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009;58:1971–7.
- Chen L, Xu WM, Zhang D. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome. Fertil Steril 2014;102:1167–74e4.
- Chakraborty P, Goswami SK, Rajani S, et al. Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance. PLoS One 2013;8:e64446.
- Banu J, Fatima P, Sultana P, et al. Association of infertile patients having polycystic ovarian syndrome with recurrent miscarriage. Mymensingh Med J: MMJ 2014;23:770–3.
- Hong Y, Xie QX, Chen CY, et al. Insulin resistance in first-trimester pregnant women with pre-pregnant glucose tolerance and history of recurrent spontaneous abortion. J Biol Regul Homeostat Agents 2013;27:225–31.
- Dravecka I. Clinical implications of polycystic ovary syndrome. Vnitrni Lekarstvi 2016;62:392–7.
- Ispasoiu CA, Chicea R, Stamatian FV, et al. High fasting insulin levels and insulin resistance may be linked to idiopathic recurrent pregnancy loss: a case-control study. Int J Endocrinol 2013;2013:576926.
- Maryam K, Bouzari Z, Basirat Z, et al. The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals. BMC Res Notes 2012;5:133.
- Kort DH, Kostolias A, Sullivan C, et al. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 2015;31:152–5.